HE4 expression in lung cancer, a meta-analysis
Authors:
- 1 July 2017
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 470, 109-114
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Province (BE2015611, H201341)
This publication has 39 references indexed in Scilit:
- HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell LinesInternational Journal of Molecular Sciences, 2013
- Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer ManagementCancer Epidemiology, Biomarkers & Prevention, 2011
- Human epididymis protein 4 reference limits and natural variation in a Nordic reference populationTumor Biology, 2011
- Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients With Ovarian CarcinomaInternational Journal of Gynecological Cancer, 2011
- Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patientsBritish Journal of Cancer, 2011
- Two new biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinomaExpert Opinion on Medical Diagnostics, 2011
- Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation studyStatistical Methods in Medical Research, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Comprehensive analysis of HE4 expression in normal and malignant human tissuesLaboratory Investigation, 2006
- The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoformsOncogene, 2002